Estimation of utility weights for major liver diseases according to disease severity in Korea

BMC Gastroenterology

Volumn 17, Issue 1, 2017, Pages

  Ock, Minsu ^a   Lim, So Yun ^b   Lee, Hyeon Jeong ^c   Kim, Seon Ha ^d   Jo, Min Woo ^b,c  

^a Ulsan University College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Dankook University   (South Korea)

Author keywords

Health related quality of life; Hepatitis B; Hepatocellular carcinoma; Liver cirrhosis; Utility weight

Indexed keywords

ADULT; ARTICLE; CANCER PALLIATIVE THERAPY; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; DISEASE BURDEN; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; KOREA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PARTIAL HEPATECTOMY; PATIENT CARE; PROGNOSIS; QUALITY OF LIFE; STANDARDIZATION; VISUAL ANALOG SCALE; COST OF ILLNESS; LIVER TUMOR; MIDDLE AGED; PATIENT ATTITUDE; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOUTH KOREA; STATISTICS; YOUNG ADULT;

ADULT; CARCINOMA, HEPATOCELLULAR; COST OF ILLNESS; FEMALE; HEALTH STATUS; HEPATITIS B, CHRONIC; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; REPUBLIC OF KOREA; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 85028716930     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/s12876-017-0660-3     Document Type: Article

References (20)

1. Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59(1):160-8.
2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128.
3. Global Burden of Disease Cancer Collaboration. Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, et al. The Global Burden of Cancer 2013. JAMA Oncol. 2015;1(4):505-27.
4. Shin HY. Lee JYCause-of-death statistics in the Republic of Korea, 2014. J Korean Med Assoc. 2016;59(3):221-32.
5. Ramos-Lopez O, Martinez-Lopez E, Roman S, Fierro NA, Panduro A. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World J Gastroenterol. 2015;21(41):11552-66.
6. Gutteling JJ, de Man RA, Busschbach JJ, Darlington AS. Overview of research on health-related quality of life in patients with chronic liver disease. Neth J Med. 2007;65(7):227-34.
7. van der Plassm HBE, de Boer JB, Stijnen T, Passchier J, de Man RA, Schalm SW. Generic and disease-specific health related quality of life of liver patients with various aetiologies: a survey. Qual Life Res. 2007;16(3):375-88.
8. Prieto L, Sacristán JA. Problems and solutions in calculating quality-adjusted life years (QALYs). Health Qual Life Outcomes. 2003;1:80.
9. Ock M, Han JW, Lee JY, Kim SH, Jo MW. Estimating quality-adjusted life-year loss due to noncommunicable diseases in Korean adults through to the year 2040. Value Health. 2015;18(1):61-6.
10. Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96:5-21.
11. McLernon DJ, Dillon J, Donnan PT. Health-state utilities in liver disease: a systematic review. Med Decis Making. 2008;28(4):582-92.
12. Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, Murray CJ, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014;12:145.
13. Ock M, Park JY, Son WS, Lee HJ, Kim SH, Jo MW. Estimation of utility weights for human papilloma virus-related health states according to disease severity. Health Qual Life Outcomes. 2016;14(1):163.
14. Giesler RB, Ashton CM, Brody B, Byrne MM, Cook K, Geraci JM, Hanita M, et al. Assessing the performance of utility techniques in the absence of a gold standard. Med Care. 1999;37(6):580-8.
15. Hadorn DC. The role of public values in setting health care priorities. Soc Sci Med. 1991;32(7):773-81.
16. Dolan P, Olsen JA, Menzel P, Richardson J. An inquiry into the different perspectives that can be used when eliciting preferences in health. Health Econ. 2003;12(7):545-51.
17. Wells CD, Murrill WB, Arguedas MR. Comparison of health-related quality of life preferences between physicians and cirrhotic patients: implications for cost-utility analyses in chronic liver disease. Dig Dis Sci. 2004;49(3):453-8.
18. Gafni A. The standard gamble method: what is being measured and how it is interpreted. Health Serv Res. 1994;29(2):207-24.
19. van Osch SM, Stiggelbout AM. The construction of standard gamble utilities. Health Econ. 2008;17(1):31-40.
20. van Osch SM, Wakker PP, van den Hout WB, Stiggelbout AM. Correcting biases in standard gamble and time tradeoff utilities. Med Decis Making. 2004;24(5):511-7.